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Case report
  A 39-year-old female presented with 1 week of  vomiting 
and abdominal pain. She was dehydrated and lethargic, but 
hemodynamically stable. Clinical examination revealed a 
palpable neck mass. Serum biochemistry showed severe 
primary hyperparathyroidism [Corrected calcium 
5.46mmol/L (range 2.17-2.46mmol/L); PTH 666pg/ml 
(range 10-65pg/ml)]. Serum phosphate [0.96mmol/l 
(range 0.79-1.37mmol/L)] and creatinine [80µmol/L 
(range 60-100µmol/L)] were normal, although urea was 
elevated [6.8mmol/L (range 2.6-6.4mmol/L)]. Thyroid 
function tests also indicated subclinical hyperthyroidism 
[TSH 0.33mU/L (range 0.4-4.0µU/L); fT4 21.2pmol/L 
(range 11.4-23.9)]. The patient reported no prior history of 
thyroid disease.
A chest radiograph (Fig. 1) showed an opacity at the base 
of  the neck, displacing the trachea to the left. There were 
no plain-film musculoskeletal manifestations of  
hyperparathyroidism.
Neck ultrasound (Fig. 2) revealed a 4.3-cm, complex, 
predominantly cystic mass below the right thyroid lobe 
with echogenic, hypervascular internal projections (Fig. 2, 
A and B). A second, circumscribed isoechoic nodule was 
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Fig. 1. 39-year-old female with parathyroid carcinoma. 
Chest radiograph.
also seen within the adjacent right thyroid lobe (Fig. 2C, 
arrow). There was no regional lymphadenopathy.
Dual-tracer nuclear parathyroid imaging (Fig. 3) was then 
performed. The anterior pinhole Technetium-99m-
Pertechnetate (72MBq/1.9mCi) image (Fig. 3A) showed 
focal tracer uptake within the right thyroid lobe, corre-
sponding to the circumscribed thyroid nodule identified on 
ultrasound. Mild suppression of  uptake was seen through-
out the remainder of  the thyroid gland. A large photopenic 
defect was seen below the right lobe, corresponding to the 
palpable complex cystic neck mass. The anterior pinhole 
technetium-99m-sestamibi (802MBq/21.7mCi) image (Fig. 
3B) (injected with the patient lying on the camera bed in 
the same position as for the thyroid scan) showed focally 
avid concordant uptake corresponding to the right thyroid 
lesion. Low-grade, discordant sestamibi uptake was seen 
below the right thyroid lobe in the region of  the palpable 
complex cystic neck mass. This uptake was confirmed on a 
pertechnetate-subtracted sestamibi image (Fig. 3C, arrow) 
and was found to localize to the solid components of  the 
complex cystic neck mass on coregistered single photon 
emission computed tomography/computed tomography 
(SPECT/CT) (Fig. 4). Delayed 4-hour sestamibi images 
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Fig. 2. 39-year-old female with parathyroid carcinoma. Neck 
sonogram.
Fig. 3. 39-year-old female 
with parathyroid carci-
noma. Dual-tracer nu-
clear parathyroid scan. A. 
Anterior pertechnetate 
image. B. Anterior ses-
tamibi image. C. Anterior 
sestamibi image 
(pertechnetate sub-
tracted).
showed no significant preferential retention of  sestamibi in 
either of  the two lesions (images not shown). The combined 
scan findings suggested dual pathology with a functioning 
thyroid nodule showing avidity for both tracers, and a pre-
dominantly cystic parathyroid lesion with only mild sesta-
mibi uptake and no pertechnetate uptake.
The patient subsequently underwent right hemithyroi-
dectomy and inferior/superior right parathyroidectomy, 
with normalization of  calcium homeostasis postoperatively. 
Gross pathology (Fig. 5A) revealed a 43x30-mm circum-
scribed mass with a smooth gray external surface. Inter-
nally, the mass showed haemorrhagic cystic contents with 
small, firm, white excrescences. Specimen histology (Fig. 
5B) confirmed a parathyroid neoplasm with a hyaline fi-
brous capsule, showing minimally pleomorphic cells. The 
foci of  vascular (Fig. 5B, arrow) and capsular invasion were 
identified, consistent with parathyroid carcinoma. The sur-
gical margins, and central neck compartment node sam-
pling, were clear. The right thyroid lobe specimen also con-
firmed a circumscribed adenoma (images not shown). 
Discussion
 Although it is a rare cause of  PTH-dependent hypercal-
cemia, parathyroid carcinoma is being diagnosed with in-
creasing frequency (1). Clinical indicators of  carcinoma 
include severe hyperparathyroidism, a palpable neck mass, 
or parathyroid gland size greater than 3 cm (2, 3). Typical 
sonographic features of  parathyroid carcinoma include 
nonhomogeneous lesion morphology and frequent cystic 
degeneration (3). In addition to characterizing parathyroid 
lesions, preliminary ultrasound also enables assessment of  
thyroid architecture. Definitive histologic features of  carci-
noma include vascular or capsular invasion (4).   
Dual-tracer parathyroid imaging is extremely useful in 
pre-operative localization of  parathyroid adenoma (sensi-
tivity 89%-98%), although it is less reliable in distinguishing 
adenoma from carcinoma (5, 6). Mitochondrial uptake of  
sestamibi in abnormal parathyroid tissue is the primary 
mechanism underpinning lesion localization (7). The para-
thyroid lesion in our case showed only subtle sestamibi up-
take, confined to the small-volume solid components of  the 
tumor. Cystic parathyroid lesions are a recognized cause of  
false-negative sestamibi imaging, and accuracy is vastly 
improved when SPECT imaging is acquired and inter-
preted in conjunction with ultrasound (8). Sestamibi uptake 
within the thyroid gland is a potential source of  false-
positive imaging (6), and initial pertechnetate imaging per-
formed in our case was useful for localizing the most in-
tense focus of  sestamibi uptake to the pertechnetate-avid 
right thyroid lobe adenoma. The thyroid lesion was also 
readily apparent on the preliminary ultrasound, and ac-
counted for the patient’s subclinical hyperthyroidism. This 
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Fig. 4. 39-year-old female with parathyroid carcinoma. Axial 
CT (A) and coregistered SPECT/CT (B) of the neck.
Fig. 5. 39-year-old female with parathyroid carcinoma. (A) 
Macrocopic parathyroid specimen and (B) histopathology 
(haematoxylin and eosin, x100) (arrow).
case underlines the importance of  concurrent imaging of  
the thyroid gland, and emphasizes the additional value of  
SPECT/CT when performing a nuclear parathyroid study, 
particularly in areas with a high prevalence of  goiter or 
thyroid disease.
Our patient also underwent whole-body Fluorine-18-
Fluorodeoxyglucose positron emission tomography (F-18-
FDG-PET; images not shown) following surgical resection, 
without evidence of  metastases. Early experience suggests 
that F-18-FDG-PET is sensitive in staging and restaging 
parathyroid carcinoma (9). Parathyroid carcinoma is gener-
ally indolent, but progressive, with overall relative survival 
at 5 and 10 years in one large series being 85.5% and 
49.1%, respectively (10).
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